SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 76 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2015. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,000 | 0.0% | 10,979 | +33.2% | 0.00% | – |
| Q4 2015 | $3,000 | -84.2% | 8,243 | -23.2% | 0.00% | – |
| Q3 2015 | $19,000 | +171.4% | 10,740 | +223.7% | 0.00% | – |
| Q2 2015 | $7,000 | +75.0% | 3,318 | +67.6% | 0.00% | – |
| Q1 2015 | $4,000 | -20.0% | 1,980 | +4.4% | 0.00% | – |
| Q4 2014 | $5,000 | -16.7% | 1,897 | +3.7% | 0.00% | – |
| Q3 2014 | $6,000 | -14.3% | 1,829 | 0.0% | 0.00% | – |
| Q2 2014 | $7,000 | -30.0% | 1,829 | -18.3% | 0.00% | – |
| Q1 2014 | $10,000 | -9.1% | 2,238 | +3.1% | 0.00% | – |
| Q4 2013 | $11,000 | -66.7% | 2,171 | -58.6% | 0.00% | – |
| Q3 2013 | $33,000 | +135.7% | 5,240 | +86.1% | 0.00% | – |
| Q2 2013 | $14,000 | – | 2,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 37,069,140 | $64,500,000 | 87.00% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $3,480,000 | 1.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 432,259 | $752,000 | 0.28% |
| Geller Advisors LLC | 187,323 | $326,000 | 0.21% |
| CAXTON CORP | 57,000 | $99,000 | 0.13% |
| Verity Asset Management, Inc. | 64,476 | $112,000 | 0.11% |
| TFS CAPITAL LLC | 367,364 | $639,000 | 0.06% |
| Cutler Capital Management, LLC | 72,500 | $126,000 | 0.06% |
| LUCAS CAPITAL MANAGEMENT | 21,100 | $37,000 | 0.02% |
| Nine Chapters Capital Management LLC | 129,700 | $226,000 | 0.02% |